Literature DB >> 16176263

Differential expression pattern of the novel serine/threonine kinase, STK33, in mice and men.

Alejandro O Mujica1, Bastienne Brauksiepe, Sigrid Saaler-Reinhardt, Stefan Reuss, Erwin R Schmidt.   

Abstract

Serine/threonine kinase 33 (STK33/Stk33) is a recently discovered gene whose inferred amino acid sequence translation displays characters typical for a calcium/calmodulin dependent kinase (CAMK). In this study we analysed the STK33/Stk33 RNA and protein distribution and the localization of the protein. The STK33/Stk33 expression pattern resembles those of some related members of the CAMK group. STK33/Stk33 displays a nonubiquitous and, in most tissues, low level of expression. It is highly expressed in testis, particularly in cells from the spermatogenic epithelia. Moreover, significant expression is detected in lung epithelia, alveolar macrophages, horizontal cells in the retina and in embryonic organs such as heart, brain and spinal cord. A possible role of STK33/Stk33 in spermatogenesis and organ ontogenesis is discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176263     DOI: 10.1111/j.1742-4658.2005.04900.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  14 in total

1.  STK33 potentiates the malignancy of hypopharyngeal squamous carcinoma: Possible relation to calcium.

Authors:  Chen Chen; Lingyan Huang; Guodong Zhang; Yang Li; Li Li; Xiaohui Bai; Wenwen Liu; Haibo Wang; Jianfeng Li
Journal:  Cancer Biol Ther       Date:  2016-07-14       Impact factor: 4.742

2.  Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.

Authors:  Fanyang Kong; Tao Sun; Xiangyu Kong; Dacheng Xie; Zhaoshen Li; Keping Xie
Journal:  Clin Cancer Res       Date:  2018-01-24       Impact factor: 12.531

3.  Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM).

Authors:  Hannah Carter; Josue Samayoa; Ralph H Hruban; Rachel Karchin
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

4.  STK33 overexpression in hypopharyngeal squamous cell carcinoma: possible role in tumorigenesis.

Authors:  Lingyan Huang; Chen Chen; Guodong Zhang; Yuanrong Ju; Jianzhong Zhang; Haibo Wang; Jianfeng Li
Journal:  BMC Cancer       Date:  2015-01-21       Impact factor: 4.430

5.  The serine/threonine kinase 33 is present and expressed in palaeognath birds but has become a unitary pseudogene in neognaths about 100 million years ago.

Authors:  Tobias Lautwein; Steffen Lerch; Daniel Schäfer; Erwin R Schmidt
Journal:  BMC Genomics       Date:  2015-07-22       Impact factor: 3.969

6.  STK33 promotes hepatocellular carcinoma through binding to c-Myc.

Authors:  Tian Yang; Bin Song; Jin Zhang; Guang-Shun Yang; Han Zhang; Wei-Feng Yu; Meng-Chao Wu; Jun-Hua Lu; Feng Shen
Journal:  Gut       Date:  2014-11-14       Impact factor: 23.059

7.  Role of serine/threonine kinase 33 methylation in colorectal cancer and its clinical significance.

Authors:  Ming-Di Yin; Si-Ping Ma; Fang Liu; Yu-Ze Chen
Journal:  Oncol Lett       Date:  2017-12-14       Impact factor: 2.967

8.  The Serine/threonine kinase Stk33 exhibits autophosphorylation and phosphorylates the intermediate filament protein Vimentin.

Authors:  Bastienne Brauksiepe; Alejandro O Mujica; Harald Herrmann; Erwin R Schmidt
Journal:  BMC Biochem       Date:  2008-09-23       Impact factor: 4.059

9.  The STK33-linked SNP rs4929949 is associated with obesity and BMI in two independent cohorts of Swedish and Greek children.

Authors:  Mathias Rask-Andersen; George Moschonis; George P Chrousos; Claude Marcus; George V Dedoussis; Robert Fredriksson; Helgi B Schiöth
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

10.  STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway.

Authors:  Yang Liu; Konrad Steinestel; Arefeh Rouhi; Milena Armacki; Kristina Diepold; Gabriela Chiosis; Thomas Simmet; Thomas Seufferlein; Ninel Azoitei
Journal:  Oncotarget       Date:  2017-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.